Trials / Terminated
TerminatedNCT01696825
Comparison of Absorption of Vaginal Diazepam Using Different Delivery Systems
COMPARISON OF ABSORPTION OF VAGINAL DIAZEPAM USING DIFFERENT DELIVERY SYSTEMS
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Jason Gilleran · Academic / Other
- Sex
- Female
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine which of three delivery systems of vaginal diazepam have the best systemic absorption, measured by serum diazepam levels. The three delivery systems are: moistened tablet, suppository or cream. Additionally the study will compare the side effects and absorption of vaginal diazepam with oral diazepam. Vaginal diazepam is used off-label vaginally to relax pelvic floor muscles and reduce pelvic pain caused from pelvic floor dysfunction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diazepam tablet, 5 mg, vaginal | Diazepam tablet, 5 mg, moistened and inserted vaginally |
| DRUG | Diazepam Suppository, 5 mg, vaginal | Compounded diazepam 5 mg suppository administered vaginally |
| DRUG | Diazepam Cream, 5 mg, Vaginal | Compounded diazepam cream, 5 mg, inserted vaginally |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2012-10-01
- Last updated
- 2014-12-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01696825. Inclusion in this directory is not an endorsement.